Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 88

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Recent advances in biopolymer-based hemostatic materials

Mecwan, Marvin, Li, Jinghang, Falcone, Natashya, Ermis, Menekse, Torres, Emily, Morales, Ramon, Hassani, Alireza, Haghniaz, Reihaneh, Mandal, Kalpana, Sharma, Saurabh, Maity, Surjendu, Zehtabi, Fatemeh, Zamanian, Behnam, Herculano, Rondinelli, Akbari, Mohsen, V. John, Johnson, Khademhosseini, Ali · 2022 · Regenerative Biomaterials

Abstract

Hemorrhage is the leading cause of trauma-related deaths, in hospital and prehospital settings. Hemostasis is a complex mechanism that involves a cascade of clotting factors and proteins that result in the formation of a strong clot. In certain surgical and emergency situations, hemostatic agents are needed to achieve faster blood coagulation to prevent the patient from experiencing a severe hemorrhagic shock. Therefore, it is critical to consider appropriate materials and designs for hemostatic agents. Many materials have been fabricated as hemostatic agents, including synthetic and naturally derived polymers. Compared to synthetic polymers, natural polymers or biopolymers, which include polysaccharides and polypeptides, have greater biocompatibility, biodegradability and processibility. Thus, in this review, we focus on biopolymer-based hemostatic agents of different forms, such as powder, particles, sponges and hydrogels. Finally, we discuss biopolymer-based hemostatic materials currently in clinical trials and offer insight into next-generation hemostats for clinical translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rb/rbac063

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 230

  1. Kauvar, 2006, Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations, J Trauma, 60, S3
  2. Donley, 2022, StatPearls
  3. Hu, 2018, Investigation of the effects of molecular parameters on the hemostatic properties of chitosan, Molecules, 23, 3147, 10.3390/molecules23123147 · doi:10.3390/molecules23123147
  4. Sung, 2021, Advances in the development of hemostatic biomaterials for medical application, Biomater Res, 25, 37, 10.1186/s40824-021-00239-1 · DOI
  5. Boon, 1993, An overview of hemostasis, Toxicol Pathol, 21, 170, 10.1177/019262339302100209 · doi:10.1177/019262339302100209
  6. Peng, 2020, Hemostatic agents for prehospital hemorrhage control: a narrative review, Mil Med Res, 7, 13
  7. Peng, 2010, Biomaterials for hemorrhage control, Trends Biomater Artif Organs, 24, 27
  8. Neuffer, 2004, Hemostatic dressings for the first responder: a review, Mil Med, 169, 716, 10.7205/MILMED.169.9.716 · DOI
  9. Pusateri, 2004, Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine, J Trauma, 57, 555, 10.1097/01.TA.0000136155.97758.CD · doi:10.1097/01.ta.0000136155.97758.cd
  10. Chiara, 2018, A systematic review on the use of topical hemostats in trauma and emergency surgery, BMC Surg, 18, 1, 10.1186/s12893-018-0398-z · DOI · Paper page
  11. Grissom, 2015, Topical hemostatic agents and dressings in the prehospital setting, Curr Opin Anaesthesiol, 28, 210, 10.1097/ACO.0000000000000166 · doi:10.1097/aco.0000000000000166
  12. Salibi, 2015, The ‘pole and tent’ pressure dressing, Emerg Med J, 32, 254, 10.1136/emermed-2014-204283 · doi:10.1136/emermed-2014-204283
  13. Ozer, 2010, A new method for hepatic resection and hemostasis: absorbable plaque and suture, Eurasian J Med, 42, 1, 10.5152/eajm.2010.01 · doi:10.5152/eajm.2010.01
  14. Vinjirayer, 2004, Securing central venous catheters: a comparison of sutures with staples, Emerg Med J, 21, 582, 10.1136/emj.2003.009860 · doi:10.1136/emj.2003.009860
  15. Kabiri, 2011, Preparation and characterization of absorbable hemostat crosslinked gelatin sponges for surgical applications, Curr Appl Phys, 11, 457, 10.1016/j.cap.2010.08.031 · doi:10.1016/j.cap.2010.08.031
  16. Khoshmohabat, 2016, Overview of agents used for emergency hemostasis, Trauma Mon, 21, 10.5812/traumamon.26023 · doi:10.5812/traumamon.26023
  17. Shkatula, 2020, Efficiency of different methods of temporary external hemostasis at the pre-hospital stage of emergency medical care, Новости хирургии, 28, 688
  18. LaPelusa, 2022, StatPearls
  19. Garmo, 2022, StatPearls
  20. Stroud, 1977, Mechanisms of zymogen activation, Annu Rev Biophys Bioeng, 6, 177, 10.1146/annurev.bb.06.060177.001141 · DOI
  21. Monroe, 2006, What does it take to make the perfect clot?, Arterioscler Thromb Vasc Biol, 26, 41, 10.1161/01.ATV.0000193624.28251.83 · DOI · Paper page
  22. Palta, 2014, Overview of the coagulation system, Indian J Anaesth, 58, 515, 10.4103/0019-5049.144643 · DOI · Paper page
  23. Barmore, 2022, StatPearls
  24. Zhong, 2021, Application and outlook of topical hemostatic materials: a narrative review, Ann Transl Med, 9, 577, 10.21037/atm-20-7160 · DOI
  25. Owens, 2010, Tissue factor and thrombosis: the clot starts here, Thromb Haemost, 104, 432, 10.1160/TH09-11-0771 · DOI · Paper page
  26. Chaudhry, 2022, StatPearls
  27. Kuchinka, 2021, Control of blood coagulation by hemocompatible material surfaces—a review, Bioengineering, 8, 215, 10.3390/bioengineering8120215 · DOI
  28. Bombeli, 2004, Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage, Br J Anaesth, 93, 275, 10.1093/bja/aeh174 · DOI
  29. Loof, 2014, The role of coagulation/fibrinolysis during Streptococcus pyogenes infection, Front Cell Infect Microbiol, 4, 128, 10.3389/fcimb.2014.00128 · DOI
  30. Wang, 2020, A natural polymer-based porous sponge with capillary-mimicking microchannels for rapid hemostasis, Acta Biomater, 114, 193, 10.1016/j.actbio.2020.07.043 · DOI
  31. Spotnitz, 2010, Fibrin sealant: past, present, and future: a brief review, World J Surg, 34, 632, 10.1007/s00268-009-0252-7 · DOI · Paper page
  32. Chan, 2015, Synthetic strategies for engineering intravenous hemostats, Bioconjug Chem, 26, 1224, 10.1021/acs.bioconjchem.5b00070 · DOI
  33. Blombäck, 1994, Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation, Thromb Res, 75, 521, 10.1016/0049-3848(94)90227-5 · DOI · Paper page
  34. Lorand, 1998, A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of γ chains by factor XIIIa, Proc Natl Acad Sci USA, 95, 537, 10.1073/pnas.95.2.537 · doi:10.1073/pnas.95.2.537
  35. Everse, 1998, Crystal structure of fragment double-D from human fibrin with two different bound ligands, Biochemistry, 37, 8637, 10.1021/bi9804129 · DOI · Paper page
  36. Soon, 2011, Modulation of fibrin matrix properties via knob: hole affinity interactions using peptide-PEG conjugates, Biomaterials, 32, 4406, 10.1016/j.biomaterials.2011.02.050 · DOI
  37. Stabenfeldt, 2011, A new direction for anticoagulants: inhibiting fibrin assembly with PEGylated fibrin knob mimics, Biotechnol Bioeng, 108, 2424, 10.1002/bit.23184 · doi:10.1002/bit.23184
  38. Chan, 2015, A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis, Sci Transl Med, 7, 277ra29, 10.1126/scitranslmed.3010383 · DOI · Paper page
  39. Kolodziej, 2012, Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging, Bioconjug Chem, 23, 548, 10.1021/bc200613e · doi:10.1021/bc200613e
  40. Kolodziej, 2014, Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents, Methods Mol Biol, 1088, 185, 10.1007/978-1-62703-673-3_13 · doi:10.1007/978-1-62703-673-3_13
  41. Brown, 2014, Ultrasoft microgels displaying emergent platelet-like behaviours, Nat Mater, 13, 1108, 10.1038/nmat4066 · DOI · Paper page
  42. Estevez, 2017, New concepts and mechanisms of platelet activation signaling, Physiology (Bethesda), 32, 162
  43. Nenna, 2021, Effect of statins on platelet activation and function: from molecular pathways to clinical effects, Biomed Res Int, 2021, 6661847, 10.1155/2021/6661847 · DOI
  44. Mitchell, 2021, Engineering precision nanoparticles for drug delivery, Nat Rev Drug Discov, 20, 101, 10.1038/s41573-020-0090-8 · DOI · Paper page
  45. Sun, 2017, Advances of blood cell-based drug delivery systems, Eur J Pharm Sci, 96, 115, 10.1016/j.ejps.2016.07.021 · DOI
  46. Girish, 2019, Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model, J Thromb Haemost, 17, 1632, 10.1111/jth.14552 · DOI
  47. Roberts, 2013, The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients, Health Technol Assess, 17, 1, 10.3310/hta17100 · DOI · Paper page
  48. Morrison, 2012, Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study, Arch Surg, 147, 113, 10.1001/archsurg.2011.287 · DOI · Paper page
  49. Brown, 2015, Design of the study of tranexamic acid during air medical prehospital transport (STAAMP) trial: addressing the knowledge gaps, Prehosp Emerg Care, 19, 79, 10.3109/10903127.2014.936635 · DOI
  50. Ng, 2015, Tranexamic acid: a clinical review, Anaesthesiol Intensive Ther, 47, 339, 10.5603/AIT.a2015.0011 · DOI · Paper page
  51. Li, 2019, Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion, Nat Commun, 10, 5562, 10.1038/s41467-019-13512-8 · DOI · Paper page
  52. Lin, 2021, RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A, Mol Ther Nucleic Acids, 24, 658, 10.1016/j.omtn.2021.03.022 · DOI
  53. Wasupalli, 2018, Fundamental Biomaterials: Polymers, 37, 10.1016/B978-0-08-102194-1.00003-7 · DOI
  54. Jin, 2021, Polysaccharide-based biomaterials in tissue engineering: a review, Tissue Eng Part B Rev, 27, 604, 10.1089/ten.teb.2020.0208 · DOI · Paper page
  55. Wang, 2021, Prospects and challenges of anticancer agents’ delivery via chitosan-based drug carriers to combat breast cancer: a review, Carbohydr Polym, 268, 118192, 10.1016/j.carbpol.2021.118192 · DOI
  56. Tsvetkov, 2020, Synthesis of biotin-tagged chitosan oligosaccharides and assessment of their immunomodulatory activity, Front Chem, 8, 554732, 10.3389/fchem.2020.554732 · DOI
  57. Zehtabi, 2017, Chitosan-sodium tetradecyl sulfate hydrogel: characterization and preclinical evaluation of a novel sclerosing embolizing agent for the treatment of endoleaks, Cardiovasc Intervent Radiol, 40, 576, 10.1007/s00270-016-1557-1 · doi:10.1007/s00270-016-1557-1
  58. Olson, 2002, Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases, Trends Cardiovasc Med, 12, 331, 10.1016/S1050-1738(02)00183-4 · doi:10.1016/s1050-1738(02)00183-4
  59. Jorgensen, 2021, Advances in biocompatibility: a prerequisite for biomedical application of biopolymers, Biopolymers for Biomedical and Biotechnological Applications., 1
  60. Lord, 2011, The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins, Biomaterials, 32, 6655, 10.1016/j.biomaterials.2011.05.062 · DOI · Paper page
  61. Kalsoom Khan, 2017, Carrageenan based bionanocomposites as drug delivery tool with special emphasis on the influence of ferromagnetic nanoparticles, Oxid Med Cell Longev, 2017, 8158315, 10.1155/2017/8158315 · DOI
  62. Gu, 2016, Gelatin blending and sonication of chitosan nanofiber mats produce synergistic effects on hemostatic functions, Int J Biol Macromol, 82, 89, 10.1016/j.ijbiomac.2015.10.009 · doi:10.1016/j.ijbiomac.2015.10.009
  63. Sorlier, 2001, Relation between the degree of acetylation and the electrostatic properties of chitin and chitosan, Biomacromolecules, 2, 765, 10.1021/bm015531+ · DOI · Paper page
  64. Denzinger, 2016, Hemostyptic property of chitosan: opportunities and pitfalls, Biomed Mater Eng, 27, 353
  65. Brown, 2009, Experience with chitosan dressings in a civilian EMS system, J Emerg Med, 37, 1, 10.1016/j.jemermed.2007.05.043 · DOI · Paper page
  66. Granville-Chapman, 2011, Pre-hospital haemostatic dressings: a systematic review, Injury, 42, 447, 10.1016/j.injury.2010.09.037 · DOI · Paper page
  67. Chen, 2018, Evaluation of absorbable hemostatic agents of polyelectrolyte complexes using carboxymethyl starch and chitosan oligosaccharide both in vitro and in vivo, Biomater Sci, 6, 3332, 10.1039/C8BM00628H · DOI
  68. Elsabahy, 2021, Design and preclinical evaluation of chitosan/kaolin nanocomposites with enhanced hemostatic efficiency, Mar Drugs, 19, 50, 10.3390/md19020050 · doi:10.3390/md19020050
  69. Wu, 2020, Fabrication of chitosan@calcium alginate microspheres with porous core and compact shell, and application as a quick traumatic hemostat, Carbohydr Polym, 247, 116669, 10.1016/j.carbpol.2020.116669 · DOI
  70. Nishiyama, 2002, Crystal structure and hydrogen-bonding system in cellulose Iβ from synchrotron X-ray and neutron fiber diffraction, J Am Chem Soc, 124, 9074, 10.1021/ja0257319 · DOI · Paper page
  71. Klemm, 2005, Cellulose: fascinating biopolymer and sustainable raw material, Angew Chem Int Ed Engl, 44, 3358, 10.1002/anie.200460587 · DOI · Paper page
  72. Cheng, 2013, Preparation and characterization of oxidized regenerated cellulose film for hemostasis and the effect of blood on its surface, Cellulose, 20, 2547, 10.1007/s10570-013-0005-5 · DOI
  73. Mertaniemi, 2016, Human stem cell decorated nanocellulose threads for biomedical applications, Biomaterials, 82, 208, 10.1016/j.biomaterials.2015.12.020 · DOI
  74. Metaxa, 2014, Cellulose-based drug carriers for cancer therapy: cytotoxic evaluation in cancer and healthy cells, Mater Lett, 132, 432, 10.1016/j.matlet.2014.06.134 · doi:10.1016/j.matlet.2014.06.134
  75. Kwak, 2015, Bacterial cellulose membrane produced by Acetobacter sp. A10 for burn wound dressing applications, Carbohydr Polym, 122, 387, 10.1016/j.carbpol.2014.10.049 · DOI
  76. Hutchinson, 2013, Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats, Cellulose, 20, 537, 10.1007/s10570-012-9828-8 · doi:10.1007/s10570-012-9828-8
  77. Ohta, 2015, Development of carboxymethyl cellulose nonwoven sheet as a novel hemostatic agent, J Biosci Bioeng, 119, 718, 10.1016/j.jbiosc.2014.10.026 · doi:10.1016/j.jbiosc.2014.10.026
  78. He, 2014, Hemostatic, antibacterial and degradable performance of the water-soluble chitosan-coated oxidized regenerated cellulose gauze, Fibers Polym, 15, 504, 10.1007/s12221-014-0504-5 · DOI
  79. Karahaliloğlu, 2017, Active nano/microbilayer hemostatic agents for diabetic rat bleeding model, J Biomed Mater Res B Appl Biomater, 105, 1573, 10.1002/jbm.b.33696 · doi:10.1002/jbm.b.33696
  80. Fan, 2021, Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent, Mater Sci Eng C Mater Biol Appl, 118, 111408, 10.1016/j.msec.2020.111408 · DOI
  81. Yan, 2017, Synthesis and properties of poly (DEX-GMA/AAc) microgel particle as a hemostatic agent, J Mater Chem B, 5, 3697, 10.1039/C7TB00768J · DOI
  82. Chen, 2020, Preparation and application of dextran and its derivatives as carriers, Int J Biol Macromol, 145, 827, 10.1016/j.ijbiomac.2019.11.151 · DOI
  83. Bhatia, 2007, Polysaccharide-based tissue adhesives for sealing corneal incisions, Curr Eye Res, 32, 1045, 10.1080/02713680701767876 · DOI
  84. Liu, 2019, A highly efficient, in situ wet-adhesive dextran derivative sponge for rapid hemostasis, Biomaterials, 205, 23, 10.1016/j.biomaterials.2019.03.016 · DOI · Paper page
  85. Artzi, 2009, Aldehyde-amine chemistry enables modulated biosealants with tissue-specific adhesion, Adv Mater, 21, 3399, 10.1002/adma.200900340 · DOI
  86. Artzi, 2011, Tuning adhesion failure strength for tissue-specific applications, Acta Biomater, 7, 67, 10.1016/j.actbio.2010.07.008 · DOI
  87. Du, 2019, Injectable hydrogel composed of hydrophobically modified chitosan/oxidized-dextran for wound healing, Mater Sci Eng C Mater Biol Appl, 104, 109930, 10.1016/j.msec.2019.109930 · DOI · Paper page
  88. Wang, 2012, Dextran and gelatin based photocrosslinkable tissue adhesive, Carbohydr Polym, 90, 1428, 10.1016/j.carbpol.2012.07.011 · DOI
  89. Liu, 2020, Efficient antibacterial dextran-montmorillonite composite sponge for rapid hemostasis with wound healing, Int J Biol Macromol, 160, 1130, 10.1016/j.ijbiomac.2020.05.140 · DOI
  90. Ghahramanpoor, 2011, A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects, J Mater Sci Mater Med, 22, 2365, 10.1007/s10856-011-4396-2 · DOI
  91. Tamayol, 2015, Hydrogel templates for rapid manufacturing of bioactive fibers and 3D constructs, Adv Healthc Mater, 4, 2146, 10.1002/adhm.201500492 · DOI
  92. Xie, 2022, Application of alginate-based hydrogels in hemostasis, Gels, 8, 109, 10.3390/gels8020109 · DOI
  93. Shi, 2016, Microspheres of carboxymethyl chitosan, sodium alginate and collagen for a novel hemostatic in vitro study, J Biomater Appl, 30, 1092, 10.1177/0885328215618354 · DOI
  94. Singh Chandel, 2022, Balance of antiperitoneal adhesion, hemostasis, and operability of compressed bilayer ultrapure alginate sponges, Biomater Adv, 137, 212825, 10.1016/j.bioadv.2022.212825 · DOI · Paper page
  95. Rong, 2015, Alginate-calcium microsphere loaded with thrombin: a new composite biomaterial for hemostatic embolization, Int J Biol Macromol, 75, 479, 10.1016/j.ijbiomac.2014.12.043 · DOI
  96. Zhai, 2019, Co-assembled supramolecular hydrogels of cell adhesive peptide and alginate for rapid hemostasis and efficacious wound healing, Soft Matter, 15, 8603, 10.1039/C9SM01296F · DOI
  97. Neuman, 2015, Hyaluronic acid and wound healing, J Pharm Pharm Sci, 18, 53, 10.18433/J3K89D · DOI
  98. An, 2019, A serotonin-modified hyaluronic acid hydrogel for multifunctional hemostatic adhesives inspired by a platelet coagulation mediator, Mater Horiz, 6, 1169, 10.1039/C9MH00157C · DOI
  99. Luo, 2019, In situ injectable hyaluronic acid/gelatin hydrogel for hemorrhage control, Mater Sci Eng C Mater Biol Appl, 98, 628, 10.1016/j.msec.2019.01.034 · DOI
  100. Hong, 2019, A strongly adhesive hemostatic hydrogel for the repair of arterial and heart bleeds, Nat Commun, 10, 1, 10.1038/s41467-019-10004-7 · DOI · Paper page
  101. Medeiros, 2021, Chondroitin sulfate from fish waste exhibits strong intracellular antioxidant potential, Braz J Med Biol Res, 54, e10730, 10.1590/1414-431x2020e10730 · DOI
  102. Garnjanagoonchorn, 2007, Determination of chondroitin sulfate from different sources of cartilage, Chem Eng Process Process Intensif, 46, 465, 10.1016/j.cep.2006.05.019 · doi:10.1016/j.cep.2006.05.019
  103. Kim, 2017, Chondroitin sulfate-based biomineralizing surface hydrogels for bone tissue engineering, ACS Appl Mater Interfaces, 9, 21639, 10.1021/acsami.7b04114 · DOI · Paper page
  104. Bourin, 1993, Glycosaminoglycans and the regulation of blood coagulation, Biochem J, 289(Pt 2), 313, 10.1042/bj2890313 · DOI · Paper page
  105. Scully, 1986, The anticoagulant properties of mast cell product, chondroitin sulphate E, Biochem Biophys Res Commun, 137, 15, 10.1016/0006-291X(86)91169-1 · doi:10.1016/0006-291x(86)91169-1
  106. Sharma, 2022, Chondroitin sulfate: emerging biomaterial for biopharmaceutical purpose and tissue engineering, Carbohydr Polym, 286, 119305, 10.1016/j.carbpol.2022.119305 · DOI
  107. Slezak, 2020, An efficacy comparison of two hemostatic agents in a porcine liver bleeding model: gelatin/thrombin flowable matrix versus collagen/thrombin powder, J Invest Surg, 33, 828, 10.1080/08941939.2019.1571130 · DOI
  108. Zhang, 2021, An injectable serotonin-chondroitin sulfate hydrogel for bio-inspired hemostatic adhesives with high wound healing capability, Mater Adv, 2, 5150, 10.1039/D1MA00137J · DOI
  109. Duncan, 2003, The dawning era of polymer therapeutics, Nat Rev Drug Discov, 2, 347, 10.1038/nrd1088 · DOI · Paper page
  110. González-Aramundiz, 2012, Polypeptides and polyaminoacids in drug delivery, Expert Opin Drug Deliv, 9, 183, 10.1517/17425247.2012.647906 · DOI
  111. Hersel, 2003, RGD modified polymers: biomaterials for stimulated cell adhesion and beyond, Biomaterials, 24, 4385, 10.1016/S0142-9612(03)00343-0 · DOI · Paper page
  112. Chow, 2008, Peptide-based biopolymers in biomedicine and biotechnology, Mater Sci Eng R Rep, 62, 125, 10.1016/j.mser.2008.04.004 · DOI · Paper page
  113. Lynn, 2004, Antigenicity and immunogenicity of collagen, J Biomed Mater Res B Appl Biomater, 71, 343, 10.1002/jbm.b.30096 · DOI · Paper page
  114. Takagi, 2018, Two-layer sheet of gelatin: a new topical hemostatic agent, Asian J Surg, 41, 124, 10.1016/j.asjsur.2016.09.007 · DOI
  115. Xie, 2021, Conjugate electrospun 3D gelatin nanofiber sponge for rapid hemostasis, Adv Healthc Mater, 10
  116. Li, 2020, Preparation and the hemostatic property study of porous gelatin microspheres both in vitro and in vivo, Colloids and Surf B Biointerfaces, 187, 110641, 10.1016/j.colsurfb.2019.110641 · doi:10.1016/j.colsurfb.2019.110641
  117. Litvinov, 2017, Fibrin mechanical properties and their structural origins, Matrix Biol, 60–61, 110, 10.1016/j.matbio.2016.08.003 · DOI · Paper page
  118. Feller, 2022, Why fibrin biomechanical properties matter for hemostasis and thrombosis, J Thromb Haemost, 20, 6, 10.1111/jth.15531 · DOI
  119. Chetter, 2017, A prospective, randomized, multicenter clinical trial on the safety and efficacy of a ready-to-use fibrin sealant as an adjunct to hemostasis during vascular surgery, Ann Vasc Surg, 45, 127, 10.1016/j.avsg.2017.06.043 · DOI
  120. Verra, 2018, The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial, PLoS One, 13, e0200804, 10.1371/journal.pone.0200804 · doi:10.1371/journal.pone.0200804
  121. Harmon, 2011, Effects of fibrin pad hemostat on the wound healing process in vivo and in vitro, Biomaterials, 32, 9594, 10.1016/j.biomaterials.2011.09.019 · doi:10.1016/j.biomaterials.2011.09.019
  122. Matonick, 2014, Hemostatic efficacy of EVARREST™, fibrin sealant patch vs. TachoSil® in a heparinized swine spleen incision model, J Invest Surg, 27, 360, 10.3109/08941939.2014.941444 · doi:10.3109/08941939.2014.941444
  123. Feroz, 2020, Keratin-based materials for biomedical applications, Bioact Mater, 5, 496, 10.1016/j.bioactmat.2020.04.007 · DOI · Paper page
  124. Rahmany, 2013, A mechanistic investigation of the effect of keratin-based hemostatic agents on coagulation, Biomaterials, 34, 2492, 10.1016/j.biomaterials.2012.12.008 · DOI
  125. Wang, 2022, Rational design of high-performance keratin-based hemostatic agents, Adv Healthc Mater, 11, e2200290, 10.1002/adhm.202200290 · DOI
  126. He, 2019, Human hair keratin hydrogels alleviate rebleeding after intracerebral hemorrhage in a rat model, ACS Biomater Sci Eng, 5, 1113, 10.1021/acsbiomaterials.8b01609 · DOI
  127. Fang, 2016, Exploration of the tight structural-mechanical relationship in mulberry and non-mulberry silkworm silks, J Mater Chem B, 4, 4337, 10.1039/C6TB01049K · DOI
  128. Panilaitis, 2003, Macrophage responses to silk, Biomaterials, 24, 3079, 10.1016/S0142-9612(03)00158-3 · DOI · Paper page
  129. Zhu, 2022, A mussel-inspired wet-adhesion hydrogel with hemostasis and local anti-inflammation for managing the development of acute wounds, Mater Des, 213, 110347, 10.1016/j.matdes.2021.110347 · DOI
  130. Lei, 2016, Preparation and hemostatic property of low molecular weight silk fibroin, J Biomater Sci Polym Ed, 27, 403, 10.1080/09205063.2015.1136918 · DOI
  131. Wei, 2020, Gellable silk fibroin-polyethylene sponge for hemostasis, Artif Cells Nanomed Biotechnol, 48, 28, 10.1080/21691401.2019.1699805 · DOI
  132. Shefa, 2019, Enhancement of hemostatic property of plant derived oxidized nanocellulose-silk fibroin based scaffolds by thrombin loading, Carbohydr Polym, 208, 168, 10.1016/j.carbpol.2018.12.056 · DOI
  133. Yang, 2018, Novel hemostatic biomolecules based on elastin-like polypeptides and the self-assembling peptide RADA-16, BMC Biotechnol, 18, 12, 10.1186/s12896-018-0422-5 · doi:10.1186/s12896-018-0422-5
  134. Wang, 2012, Molecular mechanisms of RADA16-1 peptide on fast stop bleeding in rat models, Int J Mol Sci, 13, 15279, 10.3390/ijms131115279 · DOI
  135. Wang, 2019, Design of a RADA16-based self-assembling peptide nanofiber scaffold for biomedical applications, J Biomater Sci Polym Ed, 30, 713, 10.1080/09205063.2019.1605868 · DOI
  136. Teng, 2021, Biomimetic glycopolypeptide hydrogels with tunable adhesion and microporous structure for fast hemostasis and highly efficient wound healing, Adv Funct Mater, 31, 2105628, 10.1002/adfm.202105628 · DOI · Paper page
  137. Guo, 2022, Design of functional hydrogels using smart polymer based on elastin-like polypeptides, Chem Eng J, 435, 135155, 10.1016/j.cej.2022.135155 · DOI
  138. Ma, 2021, Ultra-strong bio-glue from genetically engineered polypeptides, Nat Commun, 12, 3613, 10.1038/s41467-021-23117-9 · DOI · Paper page
  139. Lu, 2017, Mussel-inspired thermoresponsive polypeptide–pluronic copolymers for versatile surgical adhesives and hemostasis, ACS Appl Mater Interfaces, 9, 16756, 10.1021/acsami.6b16575 · DOI
  140. Lu, 2017, Versatile surgical adhesive and hemostatic materials: synthesis, properties, and application of thermoresponsive polypeptides, Chem Mater, 29, 5493, 10.1021/acs.chemmater.7b00255 · DOI
  141. Suneetha, 2019, Mussel-inspired cell/tissue-adhesive, hemostatic hydrogels for tissue engineering applications, ACS Omega, 4, 12647, 10.1021/acsomega.9b01302 · DOI
  142. Nie, 2013, Rapidly in situ forming chitosan/ε-polylysine hydrogels for adhesive sealants and hemostatic materials, Carbohydr Polym, 96, 342, 10.1016/j.carbpol.2013.04.008 · DOI
  143. Lu, 2019, Biomimetic chitosan-graft-polypeptides for improved adhesion in tissue and metal, Carbohydr Polym, 215, 20, 10.1016/j.carbpol.2019.03.065 · DOI
  144. Zhu, 2020, Fast and high strength soft tissue bioadhesives based on a peptide dendrimer with antimicrobial properties and hemostatic ability, ACS Appl Mater Interfaces, 12, 4241, 10.1021/acsami.9b18720 · DOI
  145. Xie, 2021, Conjugate electrospun 3D gelatin nanofiber sponge for rapid hemostasis, Adv Healthc Mater, 10, 2100918, 10.1002/adhm.202100918 · DOI · Paper page
  146. Huang, 2020, Degradable Gelatin-Based IPN cryogel hemostat for rapidly stopping deep noncompressible hemorrhage and simultaneously improving wound healing, Chem Mater, 32, 6595, 10.1021/acs.chemmater.0c02030 · DOI · Paper page
  147. Kheirabadi, 2008, High-pressure fibrin sealant foam: an effective hemostatic agent for treating severe parenchymal hemorrhage, J Surg Res, 144, 145, 10.1016/j.jss.2007.02.012 · doi:10.1016/j.jss.2007.02.012
  148. He, 2019, Human hair keratin hydrogels alleviate rebleeding after intracerebral hemorrhage in a rat model, ACS Biomater Sci Eng, 5, 1113, 10.1021/acsbiomaterials.8b01609 · DOI
  149. Pacheco, 2020, Use of hemostatic agents for surgical bleeding in laparoscopic partial nephrectomy: biomaterials perspective, J Biomed Mater Res, 108, 3099, 10.1002/jbm.b.34637 · doi:10.1002/jbm.b.34637
  150. Wang, 2020, The effect of form of carboxymethyl-chitosan dressings on biological properties in wound healing, Colloids Surf B Biointerfaces, 194, 111191, 10.1016/j.colsurfb.2020.111191 · doi:10.1016/j.colsurfb.2020.111191
  151. Zhang, 2020, Oxidized cellulose-based hemostatic materials, Carbohydr Polym, 230, 115585, 10.1016/j.carbpol.2019.115585 · DOI · Paper page
  152. Liu, 2022, Rapid hemostasis and excellent antibacterial cerium-containing mesoporous bioactive glass/chitosan composite sponge for hemostatic material, Mater Today Chem, 23, 100735, 10.1016/j.mtchem.2021.100735 · DOI
  153. Gutierrez, 2004, Clinical review: hemorrhagic shock, Crit Care, 8, 373, 10.1186/cc2851 · DOI
  154. Fülöp, 2013, Experimental models of hemorrhagic shock: a review, Eur Surg Res, 50, 57, 10.1159/000348808 · DOI
  155. Nichols, 2022, Recommendations for improving stop the bleed: a systematic review, Mil Med, 10.1093/milmed/usac019 · doi:10.1093/milmed/usac019
  156. Hong, 2006, The use of hemostatic agents and sealants in urology, J Urol, 176, 2367, 10.1016/j.juro.2006.07.128 · doi:10.1016/j.juro.2006.07.128
  157. di Lena, 2014, Hemostatic polymers: the concept, state of the art and perspectives, J Mater Chem B, 2, 3567, 10.1039/C3TB21739F · DOI
  158. Biswal, 2021, Biopolymers for tissue engineering applications: a review, Mater Today Proc, 41, 397, 10.1016/j.matpr.2020.09.628 · DOI · Paper page
  159. Basagaoglu Demirekin, 2015, Development of metal ion binded oxidized regenerated cellulose powder as hemostatic agent: a comparative study with in vivo performance, Ind Eng Chem Res, 54, 4906, 10.1021/ie504985b · DOI
  160. Bose, 2020, Additive manufacturing of natural biopolymers and composites for bone tissue engineering, Mater Horiz, 7, 2011, 10.1039/D0MH00277A · DOI
  161. Maleksabet, 2021, Evaluating the safety and toxicity of a modified dextran-based biopolymer as a hemostat, Curr Biotechnol, 9, 290, 10.2174/2211550109999201026090415 · DOI
  162. Lewis, 2014, Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models, ISRN Surg, 2014, 930803, 10.1155/2014/930803 · DOI
  163. Malik, 2021, Hemostatic strategies for uncontrolled bleeding: a comprehensive update, J Biomed Mater Res, 109, 1465, 10.1002/jbm.b.34806 · DOI
  164. Kordestani, 2012, A randomized controlled trial on the hemostasis of femoral artery using topical hemostatic agent, Clin Appl Thromb Hemost, 18, 501, 10.1177/1076029611432745 · doi:10.1177/1076029611432745
  165. Zheng, 2020, Research status and development potential of composite hemostatic materials, J Mater Chem B, 8, 5395, 10.1039/D0TB00906G · DOI
  166. Chen, 2018, Urushiol-functionalized mesoporous silica nanoparticles and their self-assembly into a Janus membrane as a highly efficient hemostatic material, Nanoscale, 10, 22818, 10.1039/C8NR05882B · DOI
  167. de la Harpe, 2019, The hemocompatibility of nanoparticles: a review of cell–nanoparticle interactions and hemostasis, Cells, 8, 1209, 10.3390/cells8101209 · DOI · Paper page
  168. Luo, 2016, Development and assessment of kerateine nanoparticles for use as a hemostatic agent, Mater Sci Eng C Mater Biol Appl, 63, 352, 10.1016/j.msec.2016.03.007 · DOI
  169. Yang, 2017, Design and development of polysaccharide hemostatic materials and their hemostatic mechanism, Biomater Sci, 5, 2357, 10.1039/C7BM00554G · DOI · Paper page
  170. Jegatheeswaran, 2012, In vivo evaluation of the chitosan-based haemostatic agent omni-stat® in porcine liver resection and in liver injury, Eur Surg Res, 49, 73, 10.1159/000337867 · DOI
  171. Sakoda, 2018, Injectable hemostat composed of a polyphosphate-conjugated hyaluronan hydrogel, Biomacromolecules, 19, 3280, 10.1021/acs.biomac.8b00588 · DOI
  172. Panwar, 2019, In-vitro and in-vivo evaluation of biocompatible and biodegradable calcium-modified carboxymethyl starch as a topical hemostat, Materialia, 7, 100373, 10.1016/j.mtla.2019.100373 · doi:10.1016/j.mtla.2019.100373
  173. Zhu, 2021, Hemostatic efficacy and biocompatibility evaluation of a novel absorbable porous starch hemostat, Surg Innov, 29, 367, 10.1177/15533506211046100 · doi:10.1177/15533506211046100
  174. Chen, 2000, Hybrid biomaterials for tissue engineering: a preparative method for PLA or PLGA–collagen hybrid sponges, Adv Mater, 12, 455, 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C · DOI · Paper page
  175. Rnjak-Kovacina, 2015, Lyophilized silk sponges: a versatile biomaterial platform for soft tissue engineering, ACS Biomater Sci Eng, 1, 260, 10.1021/ab500149p · DOI · Paper page
  176. Seol, 2004, Chitosan sponges as tissue engineering scaffolds for bone formation, Biotechnol Lett, 26, 1037, 10.1023/B:BILE.0000032962.79531.fd · DOI · Paper page
  177. Szymkowiak, 2021, Aligned silk sponge fabrication and perfusion culture for scalable proximal tubule tissue engineering, ACS Appl Mater Interfaces, 13, 10768, 10.1021/acsami.1c00548 · DOI
  178. Giannelli, 2021, Magnetic keratin/hydrotalcites sponges as potential scaffolds for tissue regeneration, Appl Clay Sci, 207, 106090, 10.1016/j.clay.2021.106090 · doi:10.1016/j.clay.2021.106090
  179. Zheng, 2021, A hemostatic sponge derived from skin secretion of Andrias davidianus and nanocellulose, Chem Eng J, 416, 129136, 10.1016/j.cej.2021.129136 · DOI
  180. Fan, 2021, Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent, Mater Sci Eng C Mater Biol Appl, 118, 111408, 10.1016/j.msec.2020.111408 · DOI
  181. Wei, 2021, Polysaccharides-modified chitosan as improved and rapid hemostasis foam sponges, Carbohydr Polym, 264, 118028, 10.1016/j.carbpol.2021.118028 · doi:10.1016/j.carbpol.2021.118028
  182. Udayakumar, 2021, Ecofriendly biopolymers and composites: preparation and their applications in water-treatment, Biotechnol Adv, 52, 107815, 10.1016/j.biotechadv.2021.107815 · DOI · Paper page
  183. Li, 2022, Emerging biopolymer-based bioadhesives, Macromol Biosci, 22, 2100340, 10.1002/mabi.202100340 · DOI
  184. Kuo, 2016, Osteogenic differentiation of preosteoblasts on a hemostatic gelatin sponge, Sci Rep, 6, 1, 10.1038/srep32884 · DOI
  185. Huang, 2015, Using absorbable chitosan hemostatic sponges as a promising surgical dressing, Int J Biol Macromol, 75, 322, 10.1016/j.ijbiomac.2015.01.049 · DOI
  186. Wu, 2020, Antibacterial and hemostatic thiol-modified chitosan-immobilized AgNPs composite sponges, ACS Appl Mater Interfaces, 12, 20307, 10.1021/acsami.0c05430 · DOI · Paper page
  187. Li, 2022, Polyvinyl alcohol/sodium alginate composite sponge with 3D ordered/disordered porous structure for rapidly controlling noncompressible hemorrhage, Biomater Adv, 134, 112698, 10.1016/j.msec.2022.112698 · DOI
  188. Lyu, 2022, Processing-structure-properties relationships of glycerol-plasticized silk films, Molecules, 27, 1339, 10.3390/molecules27041339 · DOI
  189. Guo, 2020, Engineering silk materials: from natural spinning to artificial processing, Appl Phys Rev, 7, 011313, 10.1063/1.5091442 · DOI
  190. Li, 2020, Design of biodegradable, implantable devices towards clinical translation, Nat Rev Mater, 5, 61, 10.1038/s41578-019-0150-z · DOI · Paper page
  191. Guo, 2020, Thermoplastic moulding of regenerated silk, Nat Mater, 19, 102, 10.1038/s41563-019-0560-8 · DOI · Paper page
  192. Teuschl, 2017, Silk fibroin based carrier system for delivery of fibrinogen and thrombin as coagulant supplements, J Biomed Mater Res A, 105, 687, 10.1002/jbm.a.35940 · DOI
  193. Hu, 2012, Visible light crosslinkable chitosan hydrogels for tissue engineering, Acta Biomater, 8, 1730, 10.1016/j.actbio.2012.01.029 · DOI · Paper page
  194. Petersen, 1984, A comparison between 2 absorbable hemostatic agents: gelatin sponge (Spongostan®) and oxidized regenerated cellulose (Surgicel®), Int J Oral Maxillofac Surg, 13, 406
  195. Kita, 2018, Point-of-care cerebrospinal fluid detection, Otolaryngol Head Neck Surg, 159, 824, 10.1177/0194599818789075 · doi:10.1177/0194599818789075
  196. Lindstrom, 1956, Complications from the use of absorbable hemostatic sponges, AMA Arch Surg, 73, 133, 10.1001/archsurg.1956.01280010135018 · doi:10.1001/archsurg.1956.01280010135018
  197. Özer, 2017, Use of gelatin sponge affects postoperative morbidity in cesarean section patients, Med Sci Monit, 23, 1141, 10.12659/MSM.899860 · DOI
  198. Blaine, 1951, Absorbable gelatin sponge in experimental surgery, Lancet, 2, 427, 10.1016/S0140-6736(51)91693-5 · doi:10.1016/s0140-6736(51)91693-5
  199. Eastridge, 2012, Death on the battlefield (2001-2011): implications for the future of combat casualty care, J Trauma Acute Care Surg, 73, S431, 10.1097/TA.0b013e3182755dcc · DOI · Paper page
  200. Holcomb, 2007, Causes of death in U.S. Special operations forces in the global war on terrorism: 2001-2004, Ann Surg, 245, 986, 10.1097/01.sla.0000259433.03754.98 · DOI · Paper page

200 of 230 shown

Cited by

Metadata

Authors
Mecwan, M., Li, J., Falcone, N., Ermis, M., Torres, E., Morales, R., Hassani, A., Haghniaz, R., Mandal, K., Sharma, S., Maity, S., Zehtabi, F., Zamanian, B., Herculano, R., Akbari, M., V. John, J., & Khademhosseini, A.
Venue
Regenerative Biomaterials
Published
2022-01-01
Volume
9
ISSN
2056-3426
Cited by
88
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent advances in biopolymer-based hemostatic materials. https://app.cochat.ai/papers/10.1093/rb/rbac063
The paper
Mecwan, M., Li, J., Falcone, N., Ermis, M., Torres, E., Morales, R., Hassani, A., Haghniaz, R., Mandal, K., Sharma, S., Maity, S., Zehtabi, F., Zamanian, B., Herculano, R., Akbari, M., V. John, J., & Khademhosseini, A. (2022). Recent advances in biopolymer-based hemostatic materials. Regenerative Biomaterials. https://doi.org/10.1093/rb/rbac063

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.